Amgen (Germany) Investor Sentiment

AMG Stock  EUR 247.75  1.75  0.70%   
About 61% of Amgen's investor base is looking to short. The analysis of current outlook of investing in Amgen Inc suggests that many traders are alarmed regarding Amgen's prospects. The current market sentiment, together with Amgen's historical and current headlines, can help investors time the market. In addition, many technical investors use Amgen Inc stock news signals to limit their universe of possible portfolio assets.
Amgen stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Amgen daily returns and investor perception about the current price of Amgen Inc as well as its diversification or hedging effects on your existing portfolios.
  
over a month ago at news.google.com         
Amgen Inc. Shares Purchased by Icon Wealth Advisors LLC - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Amgen must face lawsuit claiming it hid 10.7 billion tax bill By Reuters - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
AMGN Stock Falls Despite Upbeat Data on Immunology Drugs Heres Why - MSN
Google News at Macroaxis
over three months ago at news.google.com         
Epoch Investment Partners Inc. Sells 2,135 Shares of Amgen Inc. - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Amgen Scheduled to Post Earnings on Tuesday - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Amgen Inc. Forecasted to Earn Q4 2024 Earnings of 4.80 Per Share - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Amgen Inc. is Attracting Investor Attention Here is What You Should Know - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Inc. Shares Acquired by Oak Harvest Investment Services - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Chapin Davis Inc. Has 947000 Stake in Amgen Inc. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Why Amgen Outpaced the Stock Market Today - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Inc. Given Consensus Recommendation of Moderate Buy by Brokerages - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Top Dow Jones Stocks To Buy Today 2 To Know - Stock Market
Google News at Macroaxis
over six months ago at news.google.com         
American Trust Takes Position in Amgen Inc. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Price Target Raised to 332.00 at Royal Bank of Canada - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Is Amgen Inc the Top Dividend Stock to Buy in 2024 - Insider Monkey
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Amgen that are available to investors today. That information is available publicly through Amgen media outlets and privately through word of mouth or via Amgen internal channels. However, regardless of the origin, that massive amount of Amgen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amgen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amgen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amgen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amgen alpha.

Amgen Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Transaction History
View history of all your transactions and understand their impact on performance